Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Linking intangible resources and competition

Article Abstract:

When a company is able to compete successfully within a market the effectiveness of the intangible resources within the firm will have had an important role. Therefore firms should work towards using their intangible resources, such as relationships and competencies, to help them succeed in the most suitable market. Within industry there are several ways of competing; operational, contractural and entrepreneurial. Each type of competition requires different relationships and competencies. Firms trying to compete in markets not supported by the relevant resources may fail.

Author: Hannes, Knut, Fjeldstad, Oystein
Publisher: Elsevier B.V.
Publication Name: European Management Journal
Subject: Business, international
ISSN: 0263-2373
Year: 2000
Research, Analysis, Competition (Economics), Intangible property, Intangible assets

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Separating research from development: evidence from the pharmaceutical industry

Article Abstract:

Some companies are now beginning to view research and development as separate functions, going against the traditional practice of a single approach to research and development. This is particularly clear in the pharmaceutical industry, where research and development play a very strong role. Pharmaceutical companies which have separated research and development have selected different points at which to split up these operations, and it has proved hard to define exactly the dividing line between discovery and development.

Author: Chiesa, Vittorio
Publisher: Elsevier B.V.
Publication Name: European Management Journal
Subject: Business, international
ISSN: 0263-2373
Year: 1996
Research & Development, Scientific Research and Development Services, Industrial research, Research institutes

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Adaption to change: vertical and horizontal integration in the drug industry

Article Abstract:

Biotechnology companies became a threat to the drug industry during the 1990s. High drug prices were criticized by governments which were keen to reduce health care costs, and generic drugs became more popular. The drug industry responded to these issues by embracing horizontal and vertical integration. Vertical acquisitions allows drug companies to gain control of the entire supply chain, while horizontal acquisitions ensure that the drug companies can get involved in political debate on issues such as health reform in order to maintain their profitability levels.

Author: Karrer-Rueddi, Erna
Publisher: Elsevier B.V.
Publication Name: European Management Journal
Subject: Business, international
ISSN: 0263-2373
Year: 1997
Mergers & Acquisitions, Usage, Vertical integration, Horizontal integration

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Management, Pharmaceutical industry, Drugs
Similar abstracts:
  • Abstracts: Expert commentaries. The urge to merge in the pharmaceutical industry
  • Abstracts: Shipping to and across Central America. Africa: the going is tough. The advantages of the Caribbean
  • Abstracts: Lucent revenue rises 33% as foreign sales increase. Lucent exceeds profit estimates as sales surge. Lucent warns quarterly profit will fall short
  • Abstracts: ABN Amro has new approach to trading. ABN Amro causes stir in Italy. ABN Amro may shuffle U.S. business
  • Abstracts: Made in Manchester. The Wright spirit. Wild at heart
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.